Annual report pursuant to Section 13 and 15(d)

Condensed Balance Sheets

v3.10.0.1
Condensed Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 196,804 $ 19,538
Prepaid expenses 43,214
Total current assets 240,018 19,538
Deferred offering costs associated with initial public offering 178,283
Marketable securities held in Trust Account 159,718,098
Total assets 159,958,116 197,821
Current liabilities:    
Accounts payable 108,292 76,804
Accrued expenses 6,500 18,600
Franchise tax payable 200,000
Note payable - related parties 200,000
Total current liabilities 314,792 295,404
Deferred underwriting commissions 5,433,750
Total liabilities 5,748,542 295,404
Class A common stock, $0.0001 par value; 14,500,444 and -0- shares subject to possible redemption at $10.29 and -0- per share at December 31, 2018 and 2017, respectively 149,209,569
Stockholders' Equity (Deficit):    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at December 31, 2018 and 2017, respectively
Additional paid-in capital 4,529,248 24,612
Retained earnings (Accumulated deficit) 470,267 (122,583)
Total stockholders' equity (deficit) 5,000,005 (97,583)
Total Liabilities and Stockholders' Equity (Deficit) 159,958,116 197,821
Common Stock Class A    
Stockholders' Equity (Deficit):    
Common stock value 102
Total stockholders' equity (deficit) 102
Common Stock Class B    
Stockholders' Equity (Deficit):    
Common stock value 388 388
Total stockholders' equity (deficit) $ 388 $ 388